| Serial Number | 97660589 |
| Word Mark | MEDPRO SYSTEMS |
| Filing Date | Thursday, November 3, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 12, 2023 |
| Registration Number | 7164034 |
| Registration Date | Tuesday, September 12, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 27, 2023 |
| Goods and Services | Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs |
| Goods and Services | Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies |
| Goods and Services | Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciences, pharmaceutical, biotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; online searchable databases and information concerning historical, current and pending laws, regulations, and guidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and additional compliance requirements; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices |
| Disclaimer with Predetermined Text | "SYSTEMS" |
| Goods and Services | Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing efforts |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 21, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, April 1, 2021 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 4, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, April 1, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 21, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, March 1, 2002 |
| First Use In Commerce Date | Friday, March 1, 2002 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 21, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, April 1, 2021 |
| Party Name | MedPro Systems LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mt. Arlington, NJ 07856 |
| Party Name | MedPro Systems LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mt. Arlington, NJ 07856 |
| Party Name | MedPro Systems LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mt. Arlington, NJ 07856 |
| Event Date | Event Description |
| Tuesday, September 12, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 12, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 27, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 27, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 7, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, May 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 4, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, January 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, January 14, 2023 | NON-FINAL ACTION E-MAILED |
| Saturday, January 14, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, December 24, 2022 | ASSIGNED TO EXAMINER |
| Monday, November 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 7, 2022 | NEW APPLICATION ENTERED |